1. Home
  2. TKC vs ABCL Comparison

TKC vs ABCL Comparison

Compare TKC & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Turkcell Iletisim Hizmetleri AS

TKC

Turkcell Iletisim Hizmetleri AS

N/A

Current Price

$4.82

Market Cap

4.4B

ML Signal

N/A

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

N/A

Current Price

$11.58

Market Cap

4.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TKC
ABCL
Founded
1993
2012
Country
Turkey
Canada
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
4.1B
IPO Year
2001
2020

Fundamental Metrics

Financial Performance
Metric
TKC
ABCL
Price
$4.82
$11.58
Analyst Decision
Buy
Strong Buy
Analyst Count
2
13
Target Price
$7.38
★ $18.00
AVG Volume (30 Days)
2.3M
★ 3.2M
Earning Date
11-09-2026
11-09-2026
Dividend Yield
★ 3.83%
N/A
EPS Growth
N/A
★ 10.91
EPS
★ N/A
N/A
Revenue
N/A
★ $75,128,000.00
Revenue This Year
$30.23
N/A
Revenue Next Year
$27.60
$10.03
P/E Ratio
$26.98
★ N/A
Revenue Growth
N/A
★ 160.56
52 Week Low
$4.46
$2.75
52 Week High
$7.18
$14.98

Technical Indicators

Market Signals
Indicator
TKC
ABCL
Relative Strength Index (RSI) 50.16 45.51
Support Level $4.49 $10.65
Resistance Level $5.22 $13.21
Average True Range (ATR) 0.09 1.00
MACD 0.04 -0.06
Stochastic Oscillator 68.60 25.16

Price Performance

Historical Comparison
TKC
ABCL

About TKC Turkcell Iletisim Hizmetleri AS

Turkcell Iletisim Hizmetleri AS provides mobile telephone services in Turkey. The firm's services portfolio includes mobile and fixed voice, data, TV, and digital services over its network. The firm also operates in the Turkish Republic of Northern Cyprus, Belarus, the Netherlands, and Ukraine. It has three main reportable segments: Turkcell Turkiye, Techfin, and Other. The Turkcell Turkiye segment, which derives the majority of revenue, comprises mainly telecommunication and technology services activities.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: